Picture source: GeneCellNano website.
GeneCellNano Flagship develops new biological drugs, so-called ATMP products, biomarkers, and diagnostics for diseases with unmet clinical needs. New treatments are developed for cardiovascular diseases and age-related macular degeneration, as well as for brain, ovarian, and bladder cancer. GeneCellNano 2nd Annual Meeting is funded by the Academy of Finland and it gathers together participants from academic host institutions and industrial collaborators.
Timegate will be having a booth and our Senior Application Specialist Jacopo Zini will also be giving a speech at the event. Follow our LinkedIn and Twitter for more information!
More about the event on the GeneCellNano website.
See you there?